A PHD Finger Motif in the C Terminus of RAG2 Modulates Recombination Activity*[boxs]

The RAG1 and RAG2 proteins catalyze V(D)J recombination and are essential for generation of the diverse repertoire of antigen receptor genes and effective immune responses. RAG2 is composed of a “core” domain that is required for the recombination reaction and a C-terminal nonessential or “non-core” region. Recent evidence has emerged arguing that the non-core region plays a critical regulatory role in the recombination reaction, and mutations in this region have been identified in patients with immunodeficiencies. Here we present the first structural data for the RAG2 protein, using NMR spectroscopy to demonstrate that the C terminus of RAG2 contains a noncanonical PHD finger. All of the non-core mutations of RAG2 that are implicated in the development of immunodeficiencies are located within the PHD finger, at either zinc-coordinating residues or residues adjacent to an α-helix on the surface of the domain that participates in binding to the signaling molecules, phosphoinositides. Functional analysis of disease and phosphoinositide-binding mutations reveals novel intramolecular interactions within the non-core region and suggests that the PHD finger adopts two distinct states. We propose a model in which the equilibrium between these states modulates recombination activity. Together, these data identify the PHD finger as a novel and functionally important domain of RAG2.

[1]  Wendell A Lim,et al.  A polybasic motif allows N-WASP to act as a sensor of PIP(2) density. , 2005, Molecular cell.

[2]  I. Vetter,et al.  ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD–histone contacts , 2004, The EMBO journal.

[3]  Constantina Bakolitsa,et al.  Structural basis for vinculin activation at sites of cell adhesion , 2004, Nature.

[4]  M. Schlissel.  The spreading influence of chromatin modification , 2004, Nature Genetics.

[5]  Glenn D Prestwich,et al.  Phosphoinositide Signaling: From Affinity Probes to Pharmaceutical Targets , 2004 .

[6]  T. Gibson,et al.  Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300. , 2004, Journal of molecular biology.

[7]  Sheryl K Elkin,et al.  Ordered DNA release and target capture in RAG transposition , 2004, The EMBO journal.

[8]  S. Desiderio,et al.  Cell Cycle-dependent Accumulation in Vivo of Transposition-competent Complexes between Recombination Signal Ends and Full-length RAG Proteins* , 2004, Journal of Biological Chemistry.

[9]  P. Swanson,et al.  Full-length RAG-2, and Not Full-length RAG-1, Specifically Suppresses RAG-mediated Transposition but Not Hybrid Joint Formation or Disintegration* , 2004, Journal of Biological Chemistry.

[10]  David Jung,et al.  Unraveling V(D)J Recombination Insights into Gene Regulation , 2004, Cell.

[11]  J. Haber,et al.  V(D)J recombination and RAG-mediated transposition in yeast. , 2003, Molecular cell.

[12]  S. Desiderio,et al.  Overlapping Signals for Protein Degradation and Nuclear Localization Define a Role for Intrinsic RAG-2 Nuclear Uptake in Dividing Cells , 2003, Molecular and Cellular Biology.

[13]  Gerhard Wagner,et al.  IBIS – A tool for automated sequential assignment of protein spectra from triple resonance experiments , 2003, Journal of Biomolecular NMR.

[14]  Junying Yuan,et al.  The PHD Finger of the Chromatin-Associated Protein ING2 Functions as a Nuclear Phosphoinositide Receptor , 2003, Cell.

[15]  D. Gell,et al.  Engineering a protein scaffold from a PHD finger. , 2003, Structure.

[16]  K. Hofmann,et al.  No evidence for PHD fingers as ubiquitin ligases. , 2003, Trends in cell biology.

[17]  D. Schatz,et al.  Regulation of RAG1/RAG2‐mediated transposition by GTP and the C‐terminal region of RAG2 , 2003, The EMBO journal.

[18]  Sheryl K Elkin,et al.  The C‐terminal portion of RAG2 protects against transposition in vitro , 2003, The EMBO journal.

[19]  E. Koonin,et al.  Scores of RINGS but No PHDs in Ubiquitin Signaling , 2003, Cell cycle.

[20]  S. West,et al.  Nonhomologous end joining and V(D)J recombination require an additional factor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Fang,et al.  RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. , 2003, Seminars in cancer biology.

[22]  Sheryl K Elkin,et al.  Deletion of the RAG2 C terminus leads to impaired lymphoid development in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Jeggo,et al.  Immunological disorders and DNA repair. , 2002, Mutation research.

[24]  L. Cowell,et al.  The "dispensable" portion of RAG2 is necessary for efficient V-to-DJ rearrangement during B and T cell development. , 2002, Immunity.

[25]  Ian G. Mills,et al.  Curvature of clathrin-coated pits driven by epsin , 2002, Nature.

[26]  J. V. van Dongen,et al.  The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. , 2002, Blood.

[27]  B. Corneo,et al.  A short peptide at the C terminus is responsible for the nuclear localization of RAG2 , 2002, European journal of immunology.

[28]  S. West,et al.  Specific interaction of IP6 with human Ku70/80, the DNA‐binding subunit of DNA‐PK , 2002, The EMBO journal.

[29]  Yunmei Ma,et al.  Binding of Inositol Hexakisphosphate (IP6) to Ku but Not to DNA-PKcs * , 2002, The Journal of Biological Chemistry.

[30]  Rein Aasland,et al.  The phosphatidylinositol 3‐phosphate‐binding FYVE finger , 2002, FEBS letters.

[31]  F. Alt,et al.  Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. , 2001, Molecular cell.

[32]  W. Bickmore,et al.  Large-scale identification of mammalian proteins localized to nuclear sub-compartments. , 2001, Human molecular genetics.

[33]  B. Payrastre,et al.  Phosphoinositides: key players in cell signalling, in time and space. , 2001, Cellular signalling.

[34]  J. York,et al.  An expanded view of inositol signaling. , 2001, Advances in enzyme regulation.

[35]  N. Drouot,et al.  Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. , 2001, European journal of endocrinology.

[36]  M. Overduin,et al.  Structural mechanism of endosome docking by the FYVE domain. , 2001, Science.

[37]  T. Kigawa,et al.  Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. , 2001, Science.

[38]  K. Borden,et al.  Solution structure of the PHD domain from the KAP‐1 corepressor: structural determinants for PHD, RING and LIM zinc‐binding domains , 2001, The EMBO journal.

[39]  D. Hinton,et al.  Efficient inhibition of Escherichia coli RNA polymerase by the bacteriophage T4 AsiA protein requires that AsiA binds first to free sigma70. , 2000, Journal of molecular biology.

[40]  H. Dyson,et al.  Structure of the PHD zinc finger from human Williams-Beuren syndrome transcription factor. , 2000, Journal of molecular biology.

[41]  Ping Wang,et al.  Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.

[42]  E. Brooks,et al.  Mutations in Conserved Regions of the Predicted RAG2 Kelch Repeats Block Initiation of V(D)J Recombination and Result in Primary Immunodeficiencies , 2000, Molecular and Cellular Biology.

[43]  C. Burd,et al.  Phosphatidylinositol 3-phosphate recognition by the FYVE domain. , 1999, Molecular cell.

[44]  James H. Hurley,et al.  Crystal Structure of a Phosphatidylinositol 3-Phosphate-Specific Membrane-Targeting Motif, the FYVE Domain of Vps27p , 1999, Cell.

[45]  D. Roth,et al.  Roles of the “Dispensable” Portions of RAG-1 and RAG-2 in V(D)J Recombination , 1999, Molecular and Cellular Biology.

[46]  J. Mornon,et al.  The V(D)J recombination activating protein RAG2 consists of a six-bladed propeller and a PHD fingerlike domain, as revealed by sequence analysis , 1998, Cellular and Molecular Life Sciences CMLS.

[47]  K. Wüthrich,et al.  Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.

[48]  S. Aftimos,et al.  Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain , 1997, Nature Genetics.

[49]  William Arbuthnot Sir Lane,et al.  Identification of an early endosomal protein regulated by phosphatidylinositol 3-kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  U. Pannicke,et al.  RAG Mutations in Human B Cell-Negative SCID , 1996, Science.

[51]  M. Lieber,et al.  Mechanistic constraints on diversity in human V(D)J recombination , 1996, Molecular and cellular biology.

[52]  Christina A. Cuomo,et al.  Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps , 1995, Cell.

[53]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[54]  C. Cuomo,et al.  Analysis of regions of RAG-2 important for V(D)J recombination. , 1994, Nucleic acids research.

[55]  J E Hesse,et al.  Definition of a core region of RAG-2 that is functional in V(D)J recombination. , 1994, Nucleic acids research.

[56]  M. Lieber,et al.  Unequal signal and coding joint formation in human V(D)J recombination , 1993, Molecular and cellular biology.

[57]  D. Schatz,et al.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. , 1990, Science.

[58]  David Baltimore,et al.  The V(D)J recombination activating gene, RAG-1 , 1989, Cell.

[59]  L. Cocco,et al.  New Frontiers of Inositide-specific Phospholipase C in Nuclear Signalling Nuclear Polyphosphoinositide Metabolism , 2022 .

[60]  A. Martelli,et al.  Nuclear inositides: facts and perspectives. , 2004, Pharmacology & therapeutics.

[61]  G. Prestwich,et al.  Measurement and immunofluorescence of cellular phosphoinositides. , 2004, Methods in molecular biology.

[62]  D. Ganem,et al.  PHD domains and E3 ubiquitin ligases: viruses make the connection. , 2003, Trends in cell biology.

[63]  Charles D Schwieters,et al.  The Xplor-NIH NMR molecular structure determination package. , 2003, Journal of magnetic resonance.

[64]  M. Gellert.  V(D)J recombination: RAG proteins, repair factors, and regulation. , 2002, Annual review of biochemistry.

[65]  E. Brooks,et al.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. , 2001, Blood.